|
Public Act 099-0270
|
HB1335 Enrolled | LRB099 08955 JLK 29128 b |
|
|
AN ACT concerning health.
|
Be it enacted by the People of the State of Illinois,
|
represented in the General Assembly:
|
Section 1. Short title. This Act may be cited as the Right |
to Try Act.
|
Section 5. Findings. The General Assembly finds that the |
process of approval for investigational drugs, biological |
products, and devices in the United States often takes many |
years, and a patient with a terminal illness does not have the |
luxury of waiting until such drug, product, or device receives |
final approval from the United States Food and Drug |
Administration. As a result, the standards of the United States |
Food and Drug Administration for the use of investigational |
drugs, biological products, and devices may deny the benefits |
of potentially life-saving treatments to terminally ill |
patients. A patient with a terminal illness has a fundamental |
right to attempt to preserve his or her own life by accessing |
investigational drugs, biological products, and devices. |
Whether to use available investigational drugs, biological |
products, and devices is a decision that rightfully should be |
made by the patient with a terminal illness in consultation |
with his or her physician and is not a decision to be made by |
the government.
|
|
Section 10. Definitions. For the purposes of this Act: |
"Accident and health insurer" has the meaning given to that |
term in Section 126.2 of the Illinois Insurance Code. |
"Eligible patient" means a person who: |
(1) has a terminal illness; |
(2) has considered all other treatment options |
approved by the United States Food and Drug Administration; |
(3) has received a prescription or recommendation from |
his or her physician for an investigational drug, |
biological product, or device; |
(4) has given his or her informed consent in writing |
for the use of the investigational drug, biological |
product, or device or, if he or she is a minor or lacks the |
mental capacity to provide informed consent, a parent or |
legal guardian has given informed consent on his or her |
behalf; and |
(5) has documentation from his or her physician |
indicating that he or she has met the requirements of this |
Act. |
"Investigational drug, biological product, or device" |
means a drug, biological product, or device that has |
successfully completed Phase I of a clinical trial, but has not |
been approved for general use by the United States Food and |
Drug Administration. |
"Phase I of a clinical trial" means the stage of a clinical |
|
trial where an investigational drug, biological product, or |
device has been tested in a small group for the first time to |
evaluate its safety, determine a safe dosage range, and |
identify side effects. |
"Terminal illness" means a disease that, without |
life-sustaining measures, can reasonably be expected to result |
in death in 24 months or less.
|
Section 15. Availability of drugs, biological products, |
and devices. |
(a) A manufacturer of an investigational drug, biological |
product, or device may make available such drug, product, or |
device to eligible patients. Nothing in this Act shall be |
construed to require a manufacturer to make available any drug, |
product, or device. |
(b) A manufacturer may: |
(1) provide an investigational drug, biological |
product, or device to an eligible patient without receiving |
compensation; or |
(2) require an eligible patient to pay the costs of or |
associated with the manufacture of the investigational |
drug, biological product, or device.
|
Section 20. Insurance coverage. An accident and health |
insurer may choose to provide coverage for the cost of an |
investigational drug, biological product, or device. Nothing |
|
in this Act shall be construed to require an accident and |
health insurer to provide coverage for the cost of any |
investigational drug, biological product, or device.
|
Section 25. Penalty. Any official, employee, or agent of |
the State who blocks or attempts to block access by an eligible |
patient to an investigational drug, biological product, or |
device shall be guilty of a misdemeanor, punishable by a fine |
not to exceed $1,500.
|
Section 80. The Nursing Home Care Act is amended by |
changing Section 2-104 as follows:
|
(210 ILCS 45/2-104) (from Ch. 111 1/2, par. 4152-104)
|
Sec. 2-104.
(a) A resident shall be permitted to retain the |
services
of his own personal physician at his own expense or |
under an individual or
group plan of health insurance, or under |
any public or private
assistance program providing such |
coverage. However, the facility is
not liable for the |
negligence of any such personal physician. Every
resident shall |
be permitted to obtain from his own physician or the
physician |
attached to the facility complete and current information
|
concerning his medical diagnosis, treatment and prognosis in |
terms and
language the resident can reasonably be expected to |
understand. Every
resident shall be permitted to participate in |
the planning of his total
care and medical treatment to the |
|
extent that his condition permits. No
resident shall be |
subjected to experimental research or treatment
without first |
obtaining his informed, written consent. The conduct of
any |
experimental research or treatment shall be authorized and |
monitored
by an institutional review board appointed by the |
Director. The
membership, operating procedures and review |
criteria for the institutional
review board shall be prescribed |
under rules and regulations of the
Department and shall comply |
with the requirements for institutional review boards |
established by the federal Food and Drug Administration. No |
person who has received compensation in the prior 3 years from |
an entity that manufactures, distributes, or sells |
pharmaceuticals, biologics, or medical devices may serve on the |
institutional review board. |
The institutional review board may approve only research or |
treatment that meets the standards of the federal Food and Drug |
Administration with respect to (i) the protection of human |
subjects and (ii) financial disclosure by clinical |
investigators. The Office of State Long Term Care Ombudsman and |
the State Protection and Advocacy organization shall be given |
an opportunity to comment on any request for approval before |
the board makes a decision. Those entities shall not be |
provided information that would allow a potential human subject |
to be individually identified, unless the board asks the |
Ombudsman for help in securing information from or about the |
resident. The board shall require frequent reporting of the |
|
progress of the approved research or treatment and its impact |
on residents, including immediate reporting of any adverse |
impact to the resident, the resident's representative, the |
Office of the State Long Term Care Ombudsman, and the State |
Protection and Advocacy organization. The board may not approve |
any retrospective study of the records of any resident about |
the safety or efficacy of any care or treatment if the resident |
was under the care of the proposed researcher or a business |
associate when the care or treatment was given, unless the |
study is under the control of a researcher without any business |
relationship to any person or entity who could benefit from the |
findings of the study. |
No facility shall permit experimental research or |
treatment to be conducted on a resident, or give access to any |
person or person's records for a retrospective study about the |
safety or efficacy of any care or treatment, without the prior |
written approval of the institutional review board. No nursing |
home administrator, or person licensed by the State to provide |
medical care or treatment to any person, may assist or |
participate in any experimental research on or treatment of a |
resident, including a retrospective study, that does not have |
the prior written approval of the board. Such conduct shall be |
grounds for professional discipline by the Department of |
Financial and
Professional Regulation. |
The institutional review board may exempt from ongoing |
review research or treatment initiated on a resident before the |
|
individual's admission to a facility and for which the board |
determines there is adequate ongoing oversight by another |
institutional review board. Nothing in this Section shall |
prevent a facility, any facility employee, or any other person |
from assisting or participating in any experimental research on |
or treatment of a resident, if the research or treatment began |
before the person's admission to a facility, until the board |
has reviewed the research or treatment and decided to grant or |
deny approval or to exempt the research or treatment from |
ongoing review.
|
The institutional review board requirements of this |
subsection (a) do not apply to investigational drugs, |
biological products, or devices used by a resident with a |
terminal illness as set forth in the Right to Try Act. |
(b) All medical treatment and procedures shall be |
administered as
ordered by a physician. All new physician |
orders shall be reviewed by the
facility's director of nursing |
or charge nurse designee within 24 hours
after such orders have |
been issued to assure facility compliance with such orders.
|
All physician's orders and plans of treatment shall have |
the authentication of the physician. For the purposes of this |
subsection (b), "authentication" means an original written |
signature or an electronic signature system that allows for the |
verification of a signer's credentials. A stamp signature, with |
or without initials, is not sufficient. |
According to rules adopted by the Department, every woman |
|
resident of
child-bearing age shall receive routine |
obstetrical and gynecological
evaluations as well as necessary |
prenatal care.
|
(c) Every resident shall be permitted to refuse medical |
treatment
and to know the consequences of such action, unless |
such refusal would
be harmful to the health and safety of |
others and such harm is
documented by a physician in the |
resident's clinical record. The
resident's refusal shall free |
the facility from the obligation to
provide the treatment.
|
(d) Every resident, resident's guardian, or parent if the |
resident
is a minor shall be permitted to inspect and copy all |
his clinical and
other records concerning his care and |
maintenance kept by the facility
or by his physician. The |
facility may charge a reasonable fee for
duplication of a |
record.
|
(Source: P.A. 96-1372, eff. 7-29-10; 97-179, eff. 1-1-12.)
|
Section 90. The Medical Practice Act of 1987 is amended by |
changing Section 22 as follows:
|
(225 ILCS 60/22) (from Ch. 111, par. 4400-22)
|
(Section scheduled to be repealed on December 31, 2015)
|
Sec. 22. Disciplinary action.
|
(A) The Department may revoke, suspend, place on probation, |
reprimand, refuse to issue or renew, or take any other |
disciplinary or non-disciplinary action as the Department may |
|
deem proper
with regard to the license or permit of any person |
issued
under this Act, including imposing fines not to exceed |
$10,000 for each violation, upon any of the following grounds:
|
(1) Performance of an elective abortion in any place, |
locale,
facility, or
institution other than:
|
(a) a facility licensed pursuant to the Ambulatory |
Surgical Treatment
Center Act;
|
(b) an institution licensed under the Hospital |
Licensing Act;
|
(c) an ambulatory surgical treatment center or |
hospitalization or care
facility maintained by the |
State or any agency thereof, where such department
or |
agency has authority under law to establish and enforce |
standards for the
ambulatory surgical treatment |
centers, hospitalization, or care facilities
under its |
management and control;
|
(d) ambulatory surgical treatment centers, |
hospitalization or care
facilities maintained by the |
Federal Government; or
|
(e) ambulatory surgical treatment centers, |
hospitalization or care
facilities maintained by any |
university or college established under the laws
of |
this State and supported principally by public funds |
raised by
taxation.
|
(2) Performance of an abortion procedure in a wilful |
and wanton
manner on a
woman who was not pregnant at the |
|
time the abortion procedure was
performed.
|
(3) A plea of guilty or nolo contendere, finding of |
guilt, jury verdict, or entry of judgment or sentencing, |
including, but not limited to, convictions, preceding |
sentences of supervision, conditional discharge, or first |
offender probation, under the laws of any jurisdiction of |
the United States of any crime that is a felony.
|
(4) Gross negligence in practice under this Act.
|
(5) Engaging in dishonorable, unethical or |
unprofessional
conduct of a
character likely to deceive, |
defraud or harm the public.
|
(6) Obtaining any fee by fraud, deceit, or
|
misrepresentation.
|
(7) Habitual or excessive use or abuse of drugs defined |
in law
as
controlled substances, of alcohol, or of any |
other substances which results in
the inability to practice |
with reasonable judgment, skill or safety.
|
(8) Practicing under a false or, except as provided by |
law, an
assumed
name.
|
(9) Fraud or misrepresentation in applying for, or |
procuring, a
license
under this Act or in connection with |
applying for renewal of a license under
this Act.
|
(10) Making a false or misleading statement regarding |
their
skill or the
efficacy or value of the medicine, |
treatment, or remedy prescribed by them at
their direction |
in the treatment of any disease or other condition of the |
|
body
or mind.
|
(11) Allowing another person or organization to use |
their
license, procured
under this Act, to practice.
|
(12) Adverse action taken by another state or |
jurisdiction
against a license
or other authorization to |
practice as a medical doctor, doctor of osteopathy,
doctor |
of osteopathic medicine or
doctor of chiropractic, a |
certified copy of the record of the action taken by
the |
other state or jurisdiction being prima facie evidence |
thereof. This includes any adverse action taken by a State |
or federal agency that prohibits a medical doctor, doctor |
of osteopathy, doctor of osteopathic medicine, or doctor of |
chiropractic from providing services to the agency's |
participants.
|
(13) Violation of any provision of this Act or of the |
Medical
Practice Act
prior to the repeal of that Act, or |
violation of the rules, or a final
administrative action of |
the Secretary, after consideration of the
recommendation |
of the Disciplinary Board.
|
(14) Violation of the prohibition against fee |
splitting in Section 22.2 of this Act.
|
(15) A finding by the Disciplinary Board that the
|
registrant after
having his or her license placed on |
probationary status or subjected to
conditions or |
restrictions violated the terms of the probation or failed |
to
comply with such terms or conditions.
|
|
(16) Abandonment of a patient.
|
(17) Prescribing, selling, administering, |
distributing, giving
or
self-administering any drug |
classified as a controlled substance (designated
product) |
or narcotic for other than medically accepted therapeutic
|
purposes.
|
(18) Promotion of the sale of drugs, devices, |
appliances or
goods provided
for a patient in such manner |
as to exploit the patient for financial gain of
the |
physician.
|
(19) Offering, undertaking or agreeing to cure or treat
|
disease by a secret
method, procedure, treatment or |
medicine, or the treating, operating or
prescribing for any |
human condition by a method, means or procedure which the
|
licensee refuses to divulge upon demand of the Department.
|
(20) Immoral conduct in the commission of any act |
including,
but not limited to, commission of an act of |
sexual misconduct related to the
licensee's
practice.
|
(21) Wilfully making or filing false records or reports |
in his
or her
practice as a physician, including, but not |
limited to, false records to
support claims against the |
medical assistance program of the Department of Healthcare |
and Family Services (formerly Department of
Public Aid)
|
under the Illinois Public Aid Code.
|
(22) Wilful omission to file or record, or wilfully |
impeding
the filing or
recording, or inducing another |
|
person to omit to file or record, medical
reports as |
required by law, or wilfully failing to report an instance |
of
suspected abuse or neglect as required by law.
|
(23) Being named as a perpetrator in an indicated |
report by
the Department
of Children and Family Services |
under the Abused and Neglected Child Reporting
Act, and |
upon proof by clear and convincing evidence that the |
licensee has
caused a child to be an abused child or |
neglected child as defined in the
Abused and Neglected |
Child Reporting Act.
|
(24) Solicitation of professional patronage by any
|
corporation, agents or
persons, or profiting from those |
representing themselves to be agents of the
licensee.
|
(25) Gross and wilful and continued overcharging for
|
professional services,
including filing false statements |
for collection of fees for which services are
not rendered, |
including, but not limited to, filing such false statements |
for
collection of monies for services not rendered from the |
medical assistance
program of the Department of Healthcare |
and Family Services (formerly Department of Public Aid)
|
under the Illinois Public Aid
Code.
|
(26) A pattern of practice or other behavior which
|
demonstrates
incapacity
or incompetence to practice under |
this Act.
|
(27) Mental illness or disability which results in the
|
inability to
practice under this Act with reasonable |
|
judgment, skill or safety.
|
(28) Physical illness, including, but not limited to,
|
deterioration through
the aging process, or loss of motor |
skill which results in a physician's
inability to practice |
under this Act with reasonable judgment, skill or
safety.
|
(29) Cheating on or attempt to subvert the licensing
|
examinations
administered under this Act.
|
(30) Wilfully or negligently violating the |
confidentiality
between
physician and patient except as |
required by law.
|
(31) The use of any false, fraudulent, or deceptive |
statement
in any
document connected with practice under |
this Act.
|
(32) Aiding and abetting an individual not licensed |
under this
Act in the
practice of a profession licensed |
under this Act.
|
(33) Violating state or federal laws or regulations |
relating
to controlled
substances, legend
drugs, or |
ephedra as defined in the Ephedra Prohibition Act.
|
(34) Failure to report to the Department any adverse |
final
action taken
against them by another licensing |
jurisdiction (any other state or any
territory of the |
United States or any foreign state or country), by any peer
|
review body, by any health care institution, by any |
professional society or
association related to practice |
under this Act, by any governmental agency, by
any law |
|
enforcement agency, or by any court for acts or conduct |
similar to acts
or conduct which would constitute grounds |
for action as defined in this
Section.
|
(35) Failure to report to the Department surrender of a
|
license or
authorization to practice as a medical doctor, a |
doctor of osteopathy, a
doctor of osteopathic medicine, or |
doctor
of chiropractic in another state or jurisdiction, or |
surrender of membership on
any medical staff or in any |
medical or professional association or society,
while |
under disciplinary investigation by any of those |
authorities or bodies,
for acts or conduct similar to acts |
or conduct which would constitute grounds
for action as |
defined in this Section.
|
(36) Failure to report to the Department any adverse |
judgment,
settlement,
or award arising from a liability |
claim related to acts or conduct similar to
acts or conduct |
which would constitute grounds for action as defined in |
this
Section.
|
(37) Failure to provide copies of medical records as |
required
by law.
|
(38) Failure to furnish the Department, its |
investigators or
representatives, relevant information, |
legally requested by the Department
after consultation |
with the Chief Medical Coordinator or the Deputy Medical
|
Coordinator.
|
(39) Violating the Health Care Worker Self-Referral
|
|
Act.
|
(40) Willful failure to provide notice when notice is |
required
under the
Parental Notice of Abortion Act of 1995.
|
(41) Failure to establish and maintain records of |
patient care and
treatment as required by this law.
|
(42) Entering into an excessive number of written |
collaborative
agreements with licensed advanced practice |
nurses resulting in an inability to
adequately |
collaborate.
|
(43) Repeated failure to adequately collaborate with a |
licensed advanced practice nurse. |
(44) Violating the Compassionate Use of Medical |
Cannabis Pilot Program Act.
|
(45) Entering into an excessive number of written |
collaborative agreements with licensed prescribing |
psychologists resulting in an inability to adequately |
collaborate. |
(46) Repeated failure to adequately collaborate with a |
licensed prescribing psychologist. |
Except
for actions involving the ground numbered (26), all |
proceedings to suspend,
revoke, place on probationary status, |
or take any
other disciplinary action as the Department may |
deem proper, with regard to a
license on any of the foregoing |
grounds, must be commenced within 5 years next
after receipt by |
the Department of a complaint alleging the commission of or
|
notice of the conviction order for any of the acts described |
|
herein. Except
for the grounds numbered (8), (9), (26), and |
(29), no action shall be commenced more
than 10 years after the |
date of the incident or act alleged to have violated
this |
Section. For actions involving the ground numbered (26), a |
pattern of practice or other behavior includes all incidents |
alleged to be part of the pattern of practice or other behavior |
that occurred, or a report pursuant to Section 23 of this Act |
received, within the 10-year period preceding the filing of the |
complaint. In the event of the settlement of any claim or cause |
of action
in favor of the claimant or the reduction to final |
judgment of any civil action
in favor of the plaintiff, such |
claim, cause of action or civil action being
grounded on the |
allegation that a person licensed under this Act was negligent
|
in providing care, the Department shall have an additional |
period of 2 years
from the date of notification to the |
Department under Section 23 of this Act
of such settlement or |
final judgment in which to investigate and
commence formal |
disciplinary proceedings under Section 36 of this Act, except
|
as otherwise provided by law. The time during which the holder |
of the license
was outside the State of Illinois shall not be |
included within any period of
time limiting the commencement of |
disciplinary action by the Department.
|
The entry of an order or judgment by any circuit court |
establishing that any
person holding a license under this Act |
is a person in need of mental treatment
operates as a |
suspension of that license. That person may resume their
|
|
practice only upon the entry of a Departmental order based upon |
a finding by
the Disciplinary Board that they have been |
determined to be recovered
from mental illness by the court and |
upon the Disciplinary Board's
recommendation that they be |
permitted to resume their practice.
|
The Department may refuse to issue or take disciplinary |
action concerning the license of any person
who fails to file a |
return, or to pay the tax, penalty or interest shown in a
filed |
return, or to pay any final assessment of tax, penalty or |
interest, as
required by any tax Act administered by the |
Illinois Department of Revenue,
until such time as the |
requirements of any such tax Act are satisfied as
determined by |
the Illinois Department of Revenue.
|
The Department, upon the recommendation of the |
Disciplinary Board, shall
adopt rules which set forth standards |
to be used in determining:
|
(a) when a person will be deemed sufficiently |
rehabilitated to warrant the
public trust;
|
(b) what constitutes dishonorable, unethical or |
unprofessional conduct of
a character likely to deceive, |
defraud, or harm the public;
|
(c) what constitutes immoral conduct in the commission |
of any act,
including, but not limited to, commission of an |
act of sexual misconduct
related
to the licensee's |
practice; and
|
(d) what constitutes gross negligence in the practice |
|
of medicine.
|
However, no such rule shall be admissible into evidence in |
any civil action
except for review of a licensing or other |
disciplinary action under this Act.
|
In enforcing this Section, the Disciplinary Board or the |
Licensing Board,
upon a showing of a possible violation, may |
compel, in the case of the Disciplinary Board, any individual |
who is licensed to
practice under this Act or holds a permit to |
practice under this Act, or, in the case of the Licensing |
Board, any individual who has applied for licensure or a permit
|
pursuant to this Act, to submit to a mental or physical |
examination and evaluation, or both,
which may include a |
substance abuse or sexual offender evaluation, as required by |
the Licensing Board or Disciplinary Board and at the expense of |
the Department. The Disciplinary Board or Licensing Board shall |
specifically designate the examining physician licensed to |
practice medicine in all of its branches or, if applicable, the |
multidisciplinary team involved in providing the mental or |
physical examination and evaluation, or both. The |
multidisciplinary team shall be led by a physician licensed to |
practice medicine in all of its branches and may consist of one |
or more or a combination of physicians licensed to practice |
medicine in all of its branches, licensed chiropractic |
physicians, licensed clinical psychologists, licensed clinical |
social workers, licensed clinical professional counselors, and |
other professional and administrative staff. Any examining |
|
physician or member of the multidisciplinary team may require |
any person ordered to submit to an examination and evaluation |
pursuant to this Section to submit to any additional |
supplemental testing deemed necessary to complete any |
examination or evaluation process, including, but not limited |
to, blood testing, urinalysis, psychological testing, or |
neuropsychological testing.
The Disciplinary Board, the |
Licensing Board, or the Department may order the examining
|
physician or any member of the multidisciplinary team to |
provide to the Department, the Disciplinary Board, or the |
Licensing Board any and all records, including business |
records, that relate to the examination and evaluation, |
including any supplemental testing performed. The Disciplinary |
Board, the Licensing Board, or the Department may order the |
examining physician or any member of the multidisciplinary team |
to present testimony concerning this examination
and |
evaluation of the licensee, permit holder, or applicant, |
including testimony concerning any supplemental testing or |
documents relating to the examination and evaluation. No |
information, report, record, or other documents in any way |
related to the examination and evaluation shall be excluded by |
reason of
any common
law or statutory privilege relating to |
communication between the licensee, permit holder, or
|
applicant and
the examining physician or any member of the |
multidisciplinary team.
No authorization is necessary from the |
licensee, permit holder, or applicant ordered to undergo an |
|
evaluation and examination for the examining physician or any |
member of the multidisciplinary team to provide information, |
reports, records, or other documents or to provide any |
testimony regarding the examination and evaluation. The |
individual to be examined may have, at his or her own expense, |
another
physician of his or her choice present during all |
aspects of the examination.
Failure of any individual to submit |
to mental or physical examination and evaluation, or both, when
|
directed, shall result in an automatic suspension, without |
hearing, until such time
as the individual submits to the |
examination. If the Disciplinary Board or Licensing Board finds |
a physician unable
to practice following an examination and |
evaluation because of the reasons set forth in this Section, |
the Disciplinary
Board or Licensing Board shall require such |
physician to submit to care, counseling, or treatment
by |
physicians, or other health care professionals, approved or |
designated by the Disciplinary Board, as a condition
for |
issued, continued, reinstated, or renewed licensure to |
practice. Any physician,
whose license was granted pursuant to |
Sections 9, 17, or 19 of this Act, or,
continued, reinstated, |
renewed, disciplined or supervised, subject to such
terms, |
conditions or restrictions who shall fail to comply with such |
terms,
conditions or restrictions, or to complete a required |
program of care,
counseling, or treatment, as determined by the |
Chief Medical Coordinator or
Deputy Medical Coordinators, |
shall be referred to the Secretary for a
determination as to |
|
whether the licensee shall have their license suspended
|
immediately, pending a hearing by the Disciplinary Board. In |
instances in
which the Secretary immediately suspends a license |
under this Section, a hearing
upon such person's license must |
be convened by the Disciplinary Board within 15
days after such |
suspension and completed without appreciable delay. The
|
Disciplinary Board shall have the authority to review the |
subject physician's
record of treatment and counseling |
regarding the impairment, to the extent
permitted by applicable |
federal statutes and regulations safeguarding the
|
confidentiality of medical records.
|
An individual licensed under this Act, affected under this |
Section, shall be
afforded an opportunity to demonstrate to the |
Disciplinary Board that they can
resume practice in compliance |
with acceptable and prevailing standards under
the provisions |
of their license.
|
The Department may promulgate rules for the imposition of |
fines in
disciplinary cases, not to exceed
$10,000 for each |
violation of this Act. Fines
may be imposed in conjunction with |
other forms of disciplinary action, but
shall not be the |
exclusive disposition of any disciplinary action arising out
of |
conduct resulting in death or injury to a patient. Any funds |
collected from
such fines shall be deposited in the Medical |
Disciplinary Fund.
|
All fines imposed under this Section shall be paid within |
60 days after the effective date of the order imposing the fine |
|
or in accordance with the terms set forth in the order imposing |
the fine. |
(B) The Department shall revoke the license or
permit |
issued under this Act to practice medicine or a chiropractic |
physician who
has been convicted a second time of committing |
any felony under the
Illinois Controlled Substances Act or the |
Methamphetamine Control and Community Protection Act, or who |
has been convicted a second time of
committing a Class 1 felony |
under Sections 8A-3 and 8A-6 of the Illinois Public
Aid Code. A |
person whose license or permit is revoked
under
this subsection |
B shall be prohibited from practicing
medicine or treating |
human ailments without the use of drugs and without
operative |
surgery.
|
(C) The Department shall not revoke, suspend, place on |
probation, reprimand, refuse to issue or renew, or take any |
other disciplinary or non-disciplinary action against the |
license or permit issued under this Act to practice medicine to |
a physician based solely upon the recommendation of the |
physician to an eligible patient regarding, or prescription |
for, or treatment with, an investigational drug, biological |
product, or device. |
(D) (C) The Disciplinary Board shall recommend to the
|
Department civil
penalties and any other appropriate |
discipline in disciplinary cases when the
Board finds that a |
physician willfully performed an abortion with actual
|
knowledge that the person upon whom the abortion has been |
|
performed is a minor
or an incompetent person without notice as |
required under the Parental Notice
of Abortion Act of 1995. |
Upon the Board's recommendation, the Department shall
impose, |
for the first violation, a civil penalty of $1,000 and for a |
second or
subsequent violation, a civil penalty of $5,000.
|
(Source: P.A. 97-622, eff. 11-23-11; 98-601, eff. 12-30-13; |
98-668, eff. 6-25-14; 98-1140, eff. 12-30-14.)
|